Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Hold
1,180
0.02% 148
2026
Q1
$265K Hold
1,180
0.02% 142
2025
Q4
$284K Hold
1,180
0.02% 143
2025
Q3
$323K Hold
1,180
0.03% 137
2025
Q2
$304K Hold
1,180
0.03% 138
2025
Q1
$264K Hold
1,180
0.03% 144
2024
Q4
$270K Hold
1,180
0.03% 148
2024
Q3
$288K Sell
1,180
-225
-16% -$50.3K 0.03% 146
2024
Q2
$269K Sell
1,405
-100
-7% -$20.3K 0.03% 144
2024
Q1
$298K Hold
1,505
0.03% 139
2023
Q4
$259K Hold
1,505
0.03% 148
2023
Q3
$223K Hold
1,505
0.03% 154
2023
Q2
$329K Hold
1,505
0.04% 141
2023
Q1
$330K Hold
1,505
0.04% 139
2022
Q4
$313K Hold
1,505
0.04% 141
2022
Q3
$329K Hold
1,505
0.05% 130
2022
Q2
$315K Hold
1,505
0.04% 138
2022
Q1
$365K Sell
1,505
-90
-6% -$21.8K 0.04% 140
2021
Q4
$415K Hold
1,595
0.04% 144
2021
Q3
$420K Hold
1,595
0.05% 144
2021
Q2
$393K Hold
1,595
0.05% 148
2021
Q1
$309K Hold
1,595
0.04% 158
2020
Q4
$339K Buy
1,595
+90
+6% +$17.9K 0.05% 147
2020
Q3
$258K Hold
1,505
0.04% 137
2020
Q2
$289K Hold
1,505
0.05% 134
2020
Q1
$222K Hold
1,505
0.05% 135
2019
Q4
$233K Hold
1,505
0.04% 144
2019
Q3
$203K Buy
+1,505
New +$197K 0.04% 146

Other funds holding RMD

Woodstock Corp's RMD Position: Q2 2026 in Review

Woodstock Corp held its ResMed (RMD) position steady in Q2 2026 at 1,180 shares worth $230K. The position accounts for 0.02% of the portfolio, ranked #148.

Woodstock Corp first reported a position in RMD in Q3 2019 and has held it in 28 quarters since. The position peaked at $420K in Q3 2021. 142 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Woodstock Corp held 1,180 shares of ResMed worth $230K as of Q2 2026.
  • Woodstock Corp left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.02% of Woodstock Corp's portfolio in Q2 2026, its #148 holding.
  • Woodstock Corp first reported a position in ResMed in Q3 2019 and has held it in 28 quarters since.
  • Woodstock Corp's ResMed position peaked at $420K in Q3 2021.
  • 142 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Woodstock Corp's 13F filing for Q2 2026, filed 13 Jul 2026.